Drug Type Small molecule drug |
Synonyms 3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione, 3,7-dimethylpurine-2,6-dione, 3,7-dimethylxanthine + [2] |
Target |
Action antagonists, inhibitors |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), PDE4B inhibitors(Phosphodiesterase 4B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC7H8N4O2 |
InChIKeyYAPQBXQYLJRXSA-UHFFFAOYSA-N |
CAS Registry83-67-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Theobromin |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Cardiovascular Diseases | China | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Analgesia | Preclinical | United States | 01 May 2025 | |
| Analgesia | Preclinical | Pakistan | 01 May 2025 | |
| Inflammation | Preclinical | United States | 01 May 2025 | |
| Inflammation | Preclinical | Pakistan | 01 May 2025 | |
| Osteoarthritis | Preclinical | United States | 01 May 2025 | |
| Osteoarthritis | Preclinical | Pakistan | 01 May 2025 |
Not Applicable | 44 | nnxunqdzvu(hpiayckfae) = ipkmphdbsp vnacbukmfs (dtunmcjuod ) | - | 01 Apr 2019 | |||
Not Applicable | 44 | acoycernos(hqrubgrwdx) = rdlshuvqww vdddzjwhyx (nxoxxwxgwa ) View more | Negative | 01 Apr 2018 |





